Join
Live feed
·
PRReleasevia Quantisnow
Eyenovia Inc. logo

Eyenovia Reports First Quarter 2024 Financial Results and Provides Updates on its Myopia Phase III Program and its Two FDA Approved Commercial Products, Mydcombi and Clobetasol

ByQuantisnow·Wall Street's wire, on your screen.
EYEN· Eyenovia Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EYEN (Eyenovia Inc.) and more on Quantisnow.